Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt
Abstract
A process to form a composition comprising an asymmetrical polyene, the asymmetrical polyene comprising an “α,β unsaturated-carbonyl end” and a “C—C double bond end,” the process comprising: reacting an alkene- or polyene-containing alcohol with an alkyl ester of an α,β unsaturated carboxylic acid in the presence of at least the following components A) through C) to form a solution comprising an asymmetrical polyene: A) a lithium salt; B) a component selected from the group consisting of hydroquinone, an alkyl-substituted phenol, a substituted alkyl-substituted phenol, an alkyl-substituted hydroquinone, a substituted alkyl-substituted hydroquinone, and combinations thereof; and C) an N-oxyl-containing compound; wherein the “α,β unsaturated-carbonyl end” of the asymmetrical polyene is selected from the group consisting of structures a) through c), as described herein, and wherein the “C—C double bond end” of the asymmetrical polyene is selected from the group consisting of structures 1) through 17), as described herein.
Claims
exact text as granted — not AI-modified1 . A composition comprising:
A) an asymmetrical polyene with an “α,β unsaturated-carbonyl end” and a “C—C double bond end;” B) less than 100 ppm, based on the total weight of the composition, of an inhibitor selected from the group consisting of 4-HT and derivatives thereof; and C) less than 2000 ppm, based on the total weight of the composition, of MeHQ, wherein the “α,β unsaturated-carbonyl end” of the asymmetrical polyene is selected from the group consisting of the following:
wherein R 1 is selected from H or a C 1 -C 6 alkyl;
wherein R 2 is selected from H or a C 1 -C 6 alkyl; R 3 is selected from H, CH 3 , or CH 2 CH 3 ; R 4 is selected from H, CH 3 , or CH 2 CH 3 ; and n is from 1 to 50; and
and
wherein the “C—C double bond end” of the asymmetrical polyene is selected from the group consisting of the following:
wherein R5 is selected from H or C1-C6 alkyl;
wherein R6 is selected from H or C1-C6 alkyl;
wherein R7 is selected from H or C1-C6 alkyl;
wherein m=1 to 20.
2 . The composition of claim 1 comprising from 25 ppm to less than 100 ppm, based on the weight of the composition, of the inhibitor selected from the group consisting of 4-HT and derivatives thereof.
3 . The composition of claim 1 comprising from 50 ppm to less than 2000 ppm, based on the weight of the composition, of MeHQ.
4 . The composition of claim 1 further comprising less than 10 wt % unreacted alkene- or polyene-containing alcohol, based on the total weight of the composition.
5 . The composition of claim 4 comprising from 2 wt % to less than 10 wt % unreacted alkene- or polyene-containing alcohol, based on the total weight of the composition, wherein the unreacted alkene- or polyene-containing alcohol is polypropylene glycol allyl ether.
6 . The composition of claim 1 further comprising less than 10 wt % of Michael adducts, based on the total weight of the composition.
7 . The composition of claim 1 further comprising a lithium salt.
8 . The composition of claim 7 , wherein the lithium salt has the structure Li n X, wherein n is 1 or 2; and X is selected from the group consisting of hydroxide, oxide, halide, carbonate, bicarbonate, alkoxide, alkonate, alkenoate, phenoxide, sulfate, bisulfate, sulfonate, phosphate, phosphonate, perchlorate, and nitrate.
9 . The composition of claim 7 , wherein the lithium salt has the structure Li n X, wherein n is 1 or 2; and X is selected from the group consisting of OH − , O −2 , a halide, OR − , CO 3 −2 , HCO 3 − , and R′CO 2 − ; wherein R is selected from a C1-C8 straight chain or branched alkyl group or from an aryl group; wherein R′ is selected from either a C1-C8 straight chain or branched alkyl group, or an aryl group, or a C1-C3 alkene group.
10 . The composition of claim 7 , wherein the lithium salt is anhydrous lithium hydroxide.
11 . The composition of claim 1 further comprising unreacted alkyl ester of an α,β unsaturated carboxylic acid.
12 . The composition of claim 11 , wherein the unreacted alkyl ester of an α,β unsaturated carboxylic acid is methyl methacrylate.
13 . An asymmetrical polyene formed by reacting an alkene- or polyene-containing alcohol with an alkyl ester of an α,β unsaturated carboxylic acid in the presence of at least components A) through C) to form a solution comprising the asymmetrical polyene:
A) a lithium salt,
B) a component selected from the group consisting of hydroquinone, an alkyl-substituted phenol, a substituted alkyl-substituted phenol, an alkyl-substituted hydroquinone, a substituted alkyl-substituted hydroquinone, and combinations thereof, and
C) an N-oxyl-containing compound,
wherein the asymmetrical polyene has an “α,β unsaturated-carbonyl end” selected from the group consisting of the following:
wherein R 1 is selected from H or a C 1 -C 6 alkyl;
wherein R 2 is selected from H or a C 1 -C 6 alkyl; R 3 is selected from H, CH 3 , or CH 2 CH 3 ; R 4 is selected from H, CH 3 , or CH 2 CH 3 ; and n is from 1 to 50; and
and
a “C—C double bond end” selected from the group consisting of the following:
wherein R5 is selected from H or C1-C6 alkyl;
wherein R6 is selected from H or C1-C6 alkyl;
wherein R7 is selected from H or C1-C6 alkyl;
wherein m=1 to 20.
14 . The asymmetrical polyene of claim 13 , wherein the asymmetrical polyene is polypropylene glycol allyl ether methacrylate (PPG AEMA).Join the waitlist — get patent alerts
Track US2018037531A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.